NMDA antagonists: their role in neuroprotection.

NMDA antagonists: their role in neuroprotection.

Čájet eará veršuvnnaid (1)

Bibliográfalaš dieđut
Váldodahkkit:	Small, D, Buchan, A
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1997

Geahča maid

NMDA antagonists: their role in neuroprotection.
Dahkki: Small, D, et al.
Almmustuhtton: (1997)

Neuroprotection, excitotoxicicity and nmda antagonists
Dahkki: RUBENS JOSÉ GAGLIARDI
Almmustuhtton: (2000-06-01)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
Dahkki: Murray, R, et al.
Almmustuhtton: (1995)

Do NMDA antagonists prevent neuronal injury? No.
Dahkki: Buchan, A
Almmustuhtton: (1992)

The rise and fall of NMDA antagonists for ischemic stroke.
Dahkki: Hoyte, L, et al.
Almmustuhtton: (2004)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
Dahkki: Buchan, A
Almmustuhtton: (1990)

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
Dahkki: Xue, D, et al.
Almmustuhtton: (1994)

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
Dahkki: Xue, D, et al.
Almmustuhtton: (1992)

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
Dahkki: Buchan, A, et al.
Almmustuhtton: (1993)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
Dahkki: Li, H, et al.
Almmustuhtton: (1992)

Targeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection
Dahkki: Siqi Wang, et al.
Almmustuhtton: (2022-09-01)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
Dahkki: Buchan, A, et al.
Almmustuhtton: (1992)

Cold Pain Threshold and Role of NMDA Receptor Antagonists
Dahkki: Poroshat Nazemi, et al.
Almmustuhtton: (2019-01-01)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
Dahkki: Buchan, A, et al.
Almmustuhtton: (1992)

NMDA Receptor Antagonists for Treatment of Depression
Dahkki: Zeynep Ates-Alagoz, et al.
Almmustuhtton: (2013-04-01)

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
Dahkki: Hicks, C, et al.
Almmustuhtton: (1999)

NMDA receptor antagonists in the treatment of neurological diseases
Dahkki: I. S. Preobrazhenskaya
Almmustuhtton: (2020-10-01)

Targeting NMDA receptors in stroke: new hope in neuroprotection
Dahkki: Qiu Jing Wu, et al.
Almmustuhtton: (2018-03-01)

Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia.
Dahkki: Pulsinelli, W, et al.
Almmustuhtton: (1993)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
Dahkki: Iversen, S, et al.
Almmustuhtton: (1987)

Nobiletin as a Neuroprotectant against NMDA Receptors: An In Silico Approach
Dahkki: Sadaf Jahan, et al.
Almmustuhtton: (2022-05-01)

Alteration in NMDA receptor subunit mRNA expression in vulnerable and resistant regions of in vitro ischemic rat hippocampal slices.
Dahkki: Small, D, et al.
Almmustuhtton: (1997)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
Dahkki: A. P. Pereverzev, et al.
Almmustuhtton: (2019-12-01)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
Dahkki: Tetsuro Kikuchi
Almmustuhtton: (2020-07-01)

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
Dahkki: Caitlyn J. Bartsch, et al.
Almmustuhtton: (2022-06-01)

NMDA receptor antagonists as potential therapy in cerebellar degenerative disorders
Dahkki: Olga S. Belozor, et al.
Almmustuhtton: (2022-06-01)

Modulation of functional EEG networks by the NMDA antagonist nitrous oxide.
Dahkki: Levin Kuhlmann, et al.
Almmustuhtton: (2013-01-01)

NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments
Dahkki: I.S. Preobrazhenskaya
Almmustuhtton: (2014-10-01)

NMDA receptor antagonist ketamine impairs feature integration in visual perception.
Dahkki: Julia D I Meuwese, et al.
Almmustuhtton: (2013-01-01)

Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity
Dahkki: Soraya Wilke Saliba, et al.
Almmustuhtton: (2019-12-01)

Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys.
Dahkki: Gutnikov, SA, et al.
Almmustuhtton: (1996)

The Role of NMDA Receptor Partial Antagonist, Carbamathione, as a Therapeutic Agent for Transient Global Ischemia
Dahkki: Jigar Pravinchandra Modi, et al.
Almmustuhtton: (2023-07-01)

NMDA Antagonist Peptide Supplementation Enhances Pain Alleviation by Adrenal Medullary Transplants
Dahkki: Farinaz Nasirinezhad, et al.
Almmustuhtton: (2005-04-01)

NMDA receptor antagonists can enhance or impair learning performance in animals.
Dahkki: Mondadori, C, et al.
Almmustuhtton: (1989)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
Dahkki: Naser Osanloo, et al.
Almmustuhtton: (2015-10-01)

NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury.
Dahkki: Yang Li, et al.
Almmustuhtton: (2015-01-01)

Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain.
Dahkki: Carla M Yuede, et al.
Almmustuhtton: (2010-06-01)

Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism
Dahkki: Leandra C Constantino, et al.
Almmustuhtton: (2015-01-01)

Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke
Dahkki: Victor Li, et al.
Almmustuhtton: (2016-01-01)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
Dahkki: F. A. Zeiler
Almmustuhtton: (2015-01-01)